Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joban Vaishnav

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
JACC. Advances|February 26, 2026
Frailty Status Predicts Adverse Outcomes in Ambulatory Heart Failure With Preserved Ejection FractionRadu Tanacli, Rishi K Trivedi, Masih Tajdini, et al.
Circulation|October 29, 2020
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection FractionVirginia S Hahn, Hildur Knutsdottir, Xin Luo, et al.
JACC. Cardiooncology|April 22, 2026
Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art ReviewJoban Vaishnav, Dimitrios Bampatsias, Brian C Boursiquot, et al.
JACC. Heart Failure|December 2, 2025
Monitoring Disease Progression in Patients With Transthyretin Amyloid CardiomyopathyPablo García-Pavía, Ronald M Witteles, Thibaud Damy, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 8, 2017
Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devicesBrian A Houston, Andrea L C Schneider, Joban Vaishnav, et al.
ESC Heart Failure|December 25, 2021
Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experiencePaul J Scheel, Katherine Giuliano, Crystal Tichnell, et al.
Research Square|June 22, 2026
Development of Human iPSC-based Microphysiogical Models of Transthyretin Amyloid CardiomyopathyMarcus A C Williams, Junseong Park, Atharva R Mulay, et al.
Blood|March 4, 2026
Prognostic Factors and Progression Biomarkers in AL Amyloidosis: Mapping Current Knowledge and Critical GapsRajshekhar Chakraborty, Yevgeniy Brailovsky, Mazen Hanna, et al.
JACC. Heart Failure|August 13, 2018
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP TrialKavita Sharma, Joban Vaishnav, Rohan Kalathiya, et al.
JACC. Heart Failure|July 13, 2020
Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac AmyloidosisVirginia S Hahn, Lisa R Yanek, Joban Vaishnav, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JACC. Advances|February 26, 2026
Frailty Status Predicts Adverse Outcomes in Ambulatory Heart Failure With Preserved Ejection FractionRadu Tanacli, Rishi K Trivedi, Masih Tajdini, et al.
Circulation|October 29, 2020
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection FractionVirginia S Hahn, Hildur Knutsdottir, Xin Luo, et al.
JACC. Cardiooncology|April 22, 2026
Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art ReviewJoban Vaishnav, Dimitrios Bampatsias, Brian C Boursiquot, et al.
JACC. Heart Failure|December 2, 2025
Monitoring Disease Progression in Patients With Transthyretin Amyloid CardiomyopathyPablo García-Pavía, Ronald M Witteles, Thibaud Damy, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 8, 2017
Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devicesBrian A Houston, Andrea L C Schneider, Joban Vaishnav, et al.
ESC Heart Failure|December 25, 2021
Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experiencePaul J Scheel, Katherine Giuliano, Crystal Tichnell, et al.
Research Square|June 22, 2026
Development of Human iPSC-based Microphysiogical Models of Transthyretin Amyloid CardiomyopathyMarcus A C Williams, Junseong Park, Atharva R Mulay, et al.
Blood|March 4, 2026
Prognostic Factors and Progression Biomarkers in AL Amyloidosis: Mapping Current Knowledge and Critical GapsRajshekhar Chakraborty, Yevgeniy Brailovsky, Mazen Hanna, et al.
JACC. Heart Failure|August 13, 2018
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP TrialKavita Sharma, Joban Vaishnav, Rohan Kalathiya, et al.
JACC. Heart Failure|July 13, 2020
Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac AmyloidosisVirginia S Hahn, Lisa R Yanek, Joban Vaishnav, et al.
Pageof 4